Anticoagulation

AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s
AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s

Benoit Mores

Read time: 3m 58s
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC

Josep Rodés-Cabau

Watch time: 7m 4s
ESC 25: 4 Heart Failure Trials That Will Change My Practice

Michelle Kittleson

Watch time: 9m 41s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Jeffrey Weitz, Carolyn Lam, Davide Capodanno, et al

Watch time: 47m 57s (6 videos)
ESC 25: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 11m 8s
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Shirley Siang Ning Tan, Wei Hong Lai, Lee Len Tiong, et al

Read time: 16m 35s
Hot Line Sessions Revealed for ESC Congress 2025

ESC Congress 2025 Scientific Programme

AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s

Ton Duy Mai, Tri Huynh Quang Ho, Sy Van Hoang, et al

Read time: 19m 6s

Monika Bhandari, Akshyaya Pradhan, Pravesh Vishwakarma, et al

Read time: 27m 35s

Yugo Yamashita

TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC

Josep Rodés-Cabau

Watch time: 7m 4s

Elisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al

Read time: 18m 58s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)
Hot Line Sessions Revealed for ESC Congress 2025

ESC Congress 2025 Scientific Programme

Han Naung Tun, May Thu Kyaw, Erik Rafflenbeul, et al

Read time: 20m 11s

Jeffrey Weitz, Carolyn Lam, Davide Capodanno, et al

Watch time: 47m 57s (6 videos)

Benoit Mores

Read time: 3m 58s
AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Media

AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s
AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC

Josep Rodés-Cabau

Watch time: 7m 4s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Jeffrey Weitz, Carolyn Lam, Davide Capodanno, et al

Watch time: 47m 57s (6 videos)
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s

Broadcast

Anticoagulation

Guidelines & Statements
What’s New in the European ACS Guidelines and How Will My Practice Change?

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Broadcast

Anticoagulation

Guidelines & Statements
Edoxaban: ENGAGEing in Individualisation of DOACs

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based…

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Tratamiento con ACOD en pacientes con FA post-ICP

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s

Articles

Assessment of Direct Oral Anticoagulant Use and Clinical Outcomes among Patients with Renal Impairment at Faculty of Medicine Siriraj Hospital, Mahidol University

Apisara Lohachatinante

,

Nuttanun Kittikunkanyakit

,

Sayamon Sukkha

,

Supatat Chumnumwat

,

Rattana Chawanasuntharapot

,

Junporn Kongwatcharapong

,

Published:

26 July 2024

Citation:

European Cardiology Review 2024;19(Suppl 2):2.

DOI:

https://doi.org/10.15420/ecr.2024.19.PO1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 233
  • Downloads: Downloads 13
  • Citations: 1
  • Read time: 5m

Antiplatelet Treatment with Dual Pathway Inhibition

Tobias Geisler

,

Published:

01 July 2024

Citation:

European Cardiology Review 2024;19:e11.

DOI:

https://doi.org/10.15420/ecr.2023.52
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 326
  • Downloads: Downloads 48
  • Read time: 3m 13s

Factor XIa Inhibitors’ Future Position in AF

Maki Komiyama

,

Moritake Iguchi

,

Hiromichi Wada

,

Takanori Ikeda

,

Gheorghe-Andrei Dan

,

Koji Hasegawa

,

Published:

01 July 2024

Citation:

European Cardiology Review 2024;19:e10.

DOI:

https://doi.org/10.15420/ecr.2023.50
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 616
  • Downloads: Downloads 53
  • Citations: 1
  • Read time: 4m 22s

Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF

Phong Phan Dinh

,

Tri Huynh Quang Ho

,

Hung Manh Pham

,

Hai Hoang Nguyen

,

Minh That Ton

,

Giang Song Tran

,

Nga Quynh Vu

,

Hung Nhu Pham

,

Son Luong Cao

,

Sy Van Hoang

,

Published:

13 June 2024

Citation:

European Cardiology Review 2024;19:e05.

DOI:

https://doi.org/10.15420/ecr.2024.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 953
  • Downloads: Downloads 57
  • Citations: 1
  • Read time: 14m 35s